| Metric | Q2 2027 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 |
|---|---|---|---|---|---|
| Revenue | 15.2B +6.0% | 14.3B -19.3% | 17.7B +17.4% | 15.1B +5.0% | 14.4B |
| Cost of Revenue | 10.1B +2.7% | 9.8B -19.8% | 12.3B +20.4% | 10.2B +2.1% | 10.0B |
| Gross Profit | 5.1B +13.2% | 4.5B -18.2% | 5.5B +11.1% | 4.9B +11.3% | 4.4B |
| Operating Expenses | 3.1B +10.4% | 2.8B -10.5% | 3.1B +2.7% | 3.0B +8.3% | 2.8B |
| R&D | 0 | 0 | 0 | 0 | 0 |
| SG&A | 3.1B +10.4% | 2.8B -10.5% | 3.1B +2.7% | 3.0B +8.3% | 2.8B |
| Operating Income | 2.0B +17.9% | 1.7B -28.4% | 2.4B +24.7% | 1.9B +16.5% | 1.6B |
| EBITDA | 2.3B +15.1% | 2.0B -24.6% | 2.7B +21.6% | 2.2B +14.3% | 1.9B |
| Net Income | 1.5B +14.1% | 1.3B -24.9% | 1.8B +23.0% | 1.4B +16.0% | 1.2B |
| EPS (Basic) | $1.38 +15.0% | $1.20 -25.0% | $1.60 +23.1% | $1.30 +17.1% | $1.11 |
| EPS (Diluted) | $1.36 +14.3% | $1.19 -24.2% | $1.57 +22.7% | $1.28 +16.4% | $1.10 |
| Shares (Diluted) | 1.1B -0.3% | 1.1B -0.5% | 1.1B +0.0% | 1.1B -0.2% | 1.1B |